Form 4: Arvinas Director Leslie Norwalk Reports Stock Option Grant and RSU Acquisition
SEC Form 4 Filing
Director Leslie Norwalk reports acquisition of stock options and restricted stock units (RSUs) in Arvinas, Inc.
Summary
- On May 29, 2024, Leslie Norwalk, a director of Arvinas, Inc., reported the acquisition of 5,899 shares of common stock through restricted stock units (RSUs) and an option to purchase 9,070 shares of common stock.
- The RSUs were granted on May 29, 2024, and will vest on the earlier of May 29, 2025, or the first board meeting after the next annual stockholder meeting.
- Each RSU represents a contingent right to receive one share of Arvinas' common stock upon settlement for no consideration.
- The stock option, also granted on May 29, 2024, has an exercise price of $33.90 per share and will vest on the earlier of May 29, 2025, or the first board meeting after the next annual stockholder meeting.
- Following these transactions, Norwalk directly owns 10,020 shares of common stock and options to purchase 9,070 shares.
Sentiment
Score: 6
Explanation: The document is a neutral regulatory filing. The grant of equity to a director is generally viewed as a positive sign, but it's a routine event.
Positives
- The grant of RSUs and stock options to a director signals confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, allowing investors to monitor the actions of company directors and officers.
Comparison to Industry Standards
- Stock option and RSU grants are common forms of executive compensation in the biotechnology industry, used to align the interests of management with those of shareholders.
- Vesting schedules of one year are typical for such grants, incentivizing continued service and performance.
Stakeholder Impact
- The grant of RSUs and stock options to a director can positively impact shareholder sentiment by aligning management's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction: Grant of RSUs and stock options. |
| 05/28/2034 | Expiration date of the stock options. |
| 05/31/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.